New method for assessing red blood cell deformability


Thursday, 16 May, 2024


New method for assessing red blood cell deformability

Using image-based deep learning and dynamic shape classification techniques, researchers at the Singapore University of Technology and Design (SUTD) have developed a novel method of checking red blood cell deformability that is said to be less invasive, more cost-effective, more sensitive and higher throughput.

Red blood cells (RBCs) transport oxygen throughout the body and are able to pass through a complex of narrow capillaries due to their ability to deform. As explained by SUTD Associate Professor Ye Ai, “The deformability of RBCs is an important indicator of their health and functionality, and changes in this property can signal the presence of diseases.”

Improving current techniques to measure RBC deformability offers benefits in disease detection. By being able to detect RBC deformability changes early, patients can be diagnosed and treated earlier, improving their prognosis. Refined measurement tools will also aid researchers in understanding RBC deformability and its mechanisms better, possibly leading to new therapies.

Now, Ai and his team have presented a novel approach that can assess RBC deformability by classifying the shape of an RBC passing through a channel. Their image-based RBC deformability assessment via shape-classification approach (IRIS), described in the journal Sensors and Actuators B: Chemical, uses deep learning and works in four stages: microfluidic set-up, image capture, shape classification and deformability assessment.

RBCs are first introduced into a microfluidic channel that mimics a blood vessel’s natural environment, and they become deformed. Images of the passing RBCs are then captured by a high-speed camera and processed by a deep learning model trained to identify and classify RBCs into six predefined shapes that represent different states of RBC deformation. Finally, the frequency and type of each shape under different conditions are assessed. This provides quantitative data on RBC deformability that can be used to check treatment impacts on RBC health and functionality.

Though IRIS is not the first technique to measure RBC deformability, its microfluidics-based technology offers many advantages over traditional techniques like optical tweezers and atomic force microscopy. With microfluidics, IRIS produces a much higher throughput than traditional single-cell based techniques, but can be automated and simplified, reducing manual work by trained operators.

Microfluidic devices require much smaller sample volumes and are more cost-effective compared to equipment needed in traditional techniques. Moreover, microfluidic systems are easily integrated into other tools and scalable for mass production. These advantages make such systems highly beneficial in widespread clinical and research settings.

Microfluidics also allows for the precise control of flow conditions in the channels, enabling detailed studies of RBC behaviour in different user-controlled environments. Most importantly, microfluidic techniques involve less cell manipulation, thereby reducing the chances of artificially changing the cell’s natural state, which can happen when atomic force microscopy and optical tweezers are used.

Another advantage of IRIS is its four-shape classification (4SC). Using 4SC compared to zero shape (0SC) or two-shape classification (2SC) results in higher sensitivity due to increased resolution of deformation states, better statistical power and improved shape recognition accuracy. Essentially, 4SC classifies RBC into four shapes that include intermediate states of deformation. This provides a more refined view of RBC deformability compared to only classifying RBCs into two shapes (2SC) or none (0SC).

IRIS thus presents several benefits for use in clinical, therapeutic and research settings. Gaining detailed information on RBC deformability enables early disease detection and diagnosis, while allowing personalised treatment plans for each patient. As a high-throughput method, IRIS is also useful in drug testing where large volumes of data are generated. Finally, the technology’s ability to precisely modify the RBC’s environment, paired with its high sensitivity, allows researchers to study RBC properties under various conditions, enhancing research and clinical capabilities.

Ai aims to expand and refine the IRIS technology and to validate its results with clinical outcomes. Additionally, he plans to create a portable IRIS to increase its accessibility and application scope. All in all, he foresees IRIS will become a reliable, effective and accessible diagnostic tool in the long run.

Image credit: iStock.com/ExperienceInteriors

Related Articles

CIA Labs embraces LIMS to drive efficiency, best practice

CIA Labs recently streamlined its approval process, reduced the burden of paperwork and improved...

AI can detect COVID and other conditions from chest X-rays

As scientists compare different AI models to improve automated chest X-ray interpretation, a new...

Image integrity best practice: the problem with altering western blots

Image integrity issues are most likely to come from western blots, so researchers and...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd